摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1R,3R,5R)-1,3-dihydroxycyclohexane-1,5-carbolactone | 232952-12-4

中文名称
——
中文别名
——
英文名称
(1R,3R,5R)-1,3-dihydroxycyclohexane-1,5-carbolactone
英文别名
(1S,3S,5S)-1,3-dihydroxy-6-oxa-bicyclo[3.2.1]octan-7-one;(1S,3S,5S)-1,3-dihydroxy-6-oxabicyclo[3.2.1]octan-7-one
(1R,3R,5R)-1,3-dihydroxycyclohexane-1,5-carbolactone化学式
CAS
232952-12-4
化学式
C7H10O4
mdl
——
分子量
158.154
InChiKey
USNXVXLWPQEJSU-VPLCAKHXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.6
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    66.8
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • 1-Desoxy-2-Methylene-19-Nor-Vitamin D Analogs and Their Uses
    申请人:DeLuca Hector F.
    公开号:US20110082121A1
    公开(公告)日:2011-04-07
    This invention discloses 1-desoxy-2-methylene-19-nor-vitamin D analogs, and specifically (20S)-25-hydroxy-1-desoxy-2-methylene-19-nor-vitamin D 3 and pharmaceutical uses therefor. This compound exhibits relatively high binding activity and pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent especially for the treatment or prevention of leukemia, colon cancer, breast cancer, skin cancer or prostate cancer.
    这项发明揭示了1-去氧-2-亚甲基-19-去氧维生素D类似物,具体包括(20S)-25-羟基-1-去氧-2-亚甲基-19-去氧维生素D3及其药用。这种化合物表现出相对较高的结合活性,并在阻止未分化细胞的增殖并诱导它们分化为单核细胞方面具有显著活性,因此显示出作为抗癌剂的用途,特别是用于治疗或预防白血病、结肠癌、乳腺癌、皮肤癌或前列腺癌。
  • 1-DESOXY-2-METHYLENE-19-NOR-VITAMIN D ANALOGS AND THEIR USES
    申请人:Wisconsin Alumni Research Foundation
    公开号:EP2483240B1
    公开(公告)日:2014-09-03
  • 2-Methylene-19-Nor-Vitamin D Analogs and Their Uses
    申请人:DeLuca Hector F.
    公开号:US20120157418A1
    公开(公告)日:2012-06-21
    This invention discloses 2-methylene-19-nor-vitamin D analogs, and specifically (20S)-25-hydroxy-2-methylene-19-nor-vitamin D 3 and (20R)-25-hydroxy-2-methylene-19-nor-vitamin D 3 , as well as pharmaceutical uses therefor. These compounds exhibit relatively high binding activity and pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent especially for the treatment or prevention of osteosarcoma, leukemia, colon cancer, breast cancer, skin cancer or prostate cancer. Although these compounds have relatively low calcemic activities they may also be useful in the treatment of bone diseases due to their ability to act as prodrugs in vivo.
  • US8518917B2
    申请人:——
    公开号:US8518917B2
    公开(公告)日:2013-08-27
  • US8642579B2
    申请人:——
    公开号:US8642579B2
    公开(公告)日:2014-02-04
查看更多